An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis

Weekly methotrexate dose of 20 mg (oral or subcutaneous).

Azathioprine dose will be 2-3 mg/kg body weight per day.

Adalimumab dose will be 40 mg subcutaneously every 1-2 weeks

Infliximab dose will be 5mg/kg at week 0 and week 2, and then every 4-8 weeks.

Tocilizumab dose will be 162 mg subcutaneous injection every week or 4-8 mg/kg every 4 weeks